Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Alexander K. Arrow
AddedApr 2, 2024
UpdatedMay 31, 2026
Alexander K. Arrow

Alexander K. Arrow

Board Member, Paragonix Technologies

Crunchbase

Alexander K. Arrow's Career

Paragonix Technologies
Paragonix Technologies

Cambridge, MA, US

Board Member· Board
Zelegent
Zelegent

Irvine, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Alexander K. Arrow's Career

Paragonix Technologies
Paragonix Technologies
Public$25.8M952010Cambridge, MA, US
Board Member· Board

Leadership at Paragonix Technologies

Lisa P. AndersonLisa P. AndersonFounder
Bill EdelmanBill EdelmanBoard Member

Similar to Paragonix Technologies

TransMedicsTransMedicsAndover, MA, USMedical Devicesest. 1998TransMedicsAndover, MA, US · est. 1998

TransMedics, a Massachusetts-based manufacturer, offers tech and clinical solutions for heart and lung transplants.

Public · $721.3M212
BiomedInnovationsBiomedInnovationsDenver, NC, USMedical Devicesest. 2015BiomedInnovationsDenver, NC, US · est. 2015

BiomedInnovations: Pioneering tech for long-term storage and interaction with human tissues/organs.

Angel · $250k12
Vascular Perfusion SolutionsVascular Perfusion SolutionsSan Antonio, TX, USMedical Devicesest. 2016Vascular Perfusion SolutionsSan Antonio, TX, US · est. 2016

Vascular Perfusion Solutions: Innovating medical devices for organ preservation and resuscitation.

Angel · $6.9M18
Paragon 28Paragon 28Englewood, CO, USMedical Devicesest. 2010Paragon 28Englewood, CO, US · est. 2010

Paragon 28, Inc.: A Colorado-based medical device manufacturer specializing in foot and ankle solutions.

Public · $223.5M463
Zelegent
Zelegent
Series A$11.2M92015Irvine, CA, US
Board Member· Board

Leadership at Zelegent

David ElliotDavid ElliotCEO
Yosef KrespiYosef KrespiCo-Founder
David VolpiDavid VolpiCo-Founder

Similar to Zelegent

ZyppahZyppahLas Vegas, NV, USAnti-Snoring, Sleep Aidsest. 2012ZyppahLas Vegas, NV, US · est. 2012

ZYPPAH offers a patented, FDA-cleared anti-snoring device that secures the tongue to ensure open airways during sleep.

Angel · $125k101
ExcelentExcelentDurham, NC, USMedical Devicesest. 2022ExcelentDurham, NC, US · est. 2022

Medical device firm specializing in minimally invasive solutions for rhinosinusitis treatment.

Series A · $6M30
LinguaflexLinguaflexPittsburgh, PA, USMedical Devicesest. 2007LinguaflexPittsburgh, PA, US · est. 2007

LinguaFlex, Inc: A medical device company revolutionizing sleep apnea treatment with patented technology.

Series A · $11.7M30

Alexander K. Arrow's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Alexander K. Arrow

Dinesh PatelDinesh PatelBoard Member · Light Line MedicalRobert HuginRobert HuginBoard Member · CelgeneTiago GiraoTiago GiraoBoard Member · Landos BiopharmaNikesh AroraNikesh AroraBoard Member · Legendary EntertainmentRafael CosmanRafael CosmanFounder & CEO · TrueFiJason GarlandJason GarlandBoard Member · Acutus Medical